期刊
CLINICAL CANCER RESEARCH
卷 24, 期 23, 页码 5902-5909出版社
AMER ASSOC CANCER RESEARCH
DOI: 10.1158/1078-0432.CCR-18-1115
关键词
-
类别
资金
- NIH/NCI [1R01CA193603, 3R01CA193603-03S1, 1R01CA218405]
- National Library of Medicine [T15LM007059]
- Radiological Society of North America (RSNA) [RSCH1530]
- University of Pittsburgh Cancer Institute Precision Medicine Pilot Award from The Pittsburgh Foundation [MR2014-77613]
- University of Pittsburgh Physicians (UPP) Academic Foundation Award
Purpose: False positives in digital mammography screening lead to high recall rates, resulting in unnecessary medical procedures to patients and health care costs. This study aimed to investigate the revolutionary deep learning methods to distinguish recalled but benign mammography images from negative exams and those with malignancy. Experimental Design: Deep learning convolutional neural network (CNN) models were constructed to classify mammography images into malignant (breast cancer), negative (breast cancer free), and recalled-benign categories. A total of 14,860 images of 3,715 patients from two independent mammography datasets: Full-Field Digital Mammography Dataset (FFDM) and a digitized film dataset, Digital Dataset of Screening Mammography (DDSM), were used in various settings for training and testing the CNN models. The ROC curve was generated and the AUC was calculated as a metric of the classification accuracy. Results: Training and testing using only the FFDM dataset resulted in AUC ranging from 0.70 to 0.81. When the DDSM dataset was used, AUC ranged from 0.77 to 0.96. When datasets were combined for training and testing, AUC ranged from 0.76 to 0.91. When pretrained on a large nonmedical dataset and DDSM, the models showed consistent improvements in AUC ranging from 0.02 to 0.05 (all P > 0.05), compared with pretraining only on the nonmedical dataset. Conclusions: This study demonstrates that automatic deep learning CNN methods can identify nuanced mammographic imaging features to distinguish recalled-benign images from malignant and negative cases, which may lead to a computerized clinical toolkit to help reduce false recalls.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据